The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10700 malaria professionals are enjoying the free benefits of MalariaWorld today

vivax

Current status of Plasmodium vivax vaccine

October 25, 2009 - 16:36 -- Ingeborg van Schayk
Tags: 
Author(s): 
Myriam Arévalo-Herrera, Chetan Chitnis and Sócrates Herrera
Reference: 
Human Vaccines, Volume 6, Issue 1, January 2010

The increasing P. vivax drug resistance and reports of severe and lethal cases, the relapsing parasite behavior and the existence of Plasmodium spp co-infections must prompt more investment and greater efforts for the development of P. vivax vaccine.

Medical Treatment: 

Vaccines against malaria: Perspectives from Papua New Guinea

October 25, 2009 - 16:21 -- Bart G.J. Knols
Author(s): 
Ivo Mueller, Blaise Genton, Inoni Betuela and Michael P. Alpers
Reference: 
Human Vaccines, Volume 6, Issue 1, January 2010

Despite its small population and isolate location Papua New Guinea (PNG) with a malaria burden comparable to sub-Saharan Africa, its intense transmission of all 4 human Plasmodium species and an unrivalled combination of environmental and human variation offers unique perspectives on malaria vaccines.

Technology: 
Continent: 
Medical Condition: 
Medical Treatment: 
Subscribe to RSS - vivax